Reduction of immunosuppressive therapy after renal transplantation: a randomized study
Heering, P.; Westhoff, A.; Ivens, K.; Kutkuhn, B.; Grabensee, B.
Transplantation Proceedings 26(5): 2530-2532
1994
ISSN/ISBN: 0041-1345 PMID: 7940778 Document Number: 430444
Document emailed within 1 workday
Related Documents
Bechstein, W.O.; Neuhaus, P.; McMaster, P.; Calne, R.; Pichlmayr, R.; Otto, G.; Williams, R.; Ericzon, B.G.; Bismuth, H. 1996: Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation Transplantation Proceedings 28(2): 1008-1010Heaf, J. 1993: Bone marrow function during quadruple immunosuppressive therapy after renal transplantation Clinical Nephrology 40(6): 332-338
Caletti, C.; Granata, S.; Tomei, P.; Dalla Gassa, A.; Lupo, A.; Zaza, G. 2015: Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 32(3)
Canafax, D.M.; Carleton, B.C.; Matas, A.J.; Payne, W.D.; Dunn, D.L.; Sutherland, D.E.; Najarian, J.S. 1993: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy Transplantation Proceedings 25(1 Pt 2): 1692-1693
Yun, Y.S.; Kim, B.J.; Hong, S.P.; Lee, T.W.; Lim, C.G.; Kim, M.J. 1996: Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation Transplantation Proceedings 28(3): 1561-1564
Gupta, K.L.; Ghosh, A.K.; Kochhar, R.; Jha, V.; Chakrabarti, A.; Sakhuja, V. 1994: Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols American Journal of Gastroenterology 89(7): 1062-1065
Grino, J.M. 1994: BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation Annals of Internal Medicine 121(5): 345-347
Tanaka, M.; Otobe, Y.; Hashimoto, T.; Shimizu, Y.; Suzuki, T.; Nakamura, Y.; Itoh, K.; Satoh, M.; Ueda, N.; Manabe, T. 1996: Reduction of immunosuppressive agents after living related donor liver transplantation Transplantation Proceedings 28(4): 2402-2403
Grundmann, R.; Wienand, P.; Hesse, U. 1987: Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial Transplantation Proceedings 19(5): 4033-4034
Scarpioni, R.; Michieletti, E.; Cristinelli, L.; Ugolotti, U.; Scolari, F.; Venturelli, C.; Cancarini, G.; Pecchini, P.; Malberti, F.; Maroldi, R.; Rozzi, G.; Olivetti, L. 2005: Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER) Journal of Nephrology 18(4): 423-428
Kootte, A.M.; Lensen, L.M.; van Bockel, J.H.; Paul, L.C. 1988: A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation Transplantation Proceedings 20(3 Suppl 3: 136-139
Basić-Jukić, N.; Kes, P. 2011: Novel immunosuppressive drugs in renal transplantation Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 361-364
Costanzo-Nordin, M.R.; O'Sullivan, E.J.; Johnson, M.R.; Winters, G.L.; Pifarre, R.; Radvany, R.; Zucker, M.J.; Scanlon, P.J.; Robinson, J.A. 1990: Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation Journal of Heart Transplantation 9(3 Part 2): 306-315
Koyama, I.; Amemiya, H.; Taguchi, Y.; Watanabe, T.; Nagashima, N.; Suzuki, S.; Omoto, R. 1991: Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation Transplantation Proceedings 23(1 Part 2): 1096-1098
Eklund, B.; Ahonen, J.; Häyry, P.; Kauste, A.; von Willebrand, E.; Lindström, B.L. 1981: Comparison of two different immunosuppressive dosages of methylprednisolone in clinical renal transplantation Scandinavian Journal of Urology and Nephrology. Supplementum 64: 179-184
Seybold, D.; Gessler, U.; Sigel, A. 1982: Immunosuppressive therapy following kidney transplantation Der Urologe. Ausg. a 21(5): 274-279
van Riemsdijk, I.C.; Mulder, P.G.; de Fijter, J.W.; Bruijn, J.A.; van Hooff, J.P.; Hoitsma, A.J.; Tegzess, A.M.; Weimar, W. 2000: Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study Transplantation 70(1): 122-126
Elli, A.; Rivolta, R.; Palazzi, P.; Mascaretti, L.; Puglisi, G.; Parenti, M.; Sioli, V.; Di Palo, F.Q. 1990: Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects Transplantation Proceedings 22(4): 1689-1690
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27
Ruffault, A.; Fauconnier, B.; Cartier, F.; Launois, B. 1975: Herpes simplex virus antibodies in 18 patients submitted to immunosuppressive agents after renal transplantation Pathologie-Biologie 23(5): 371-374